Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s40779-020-00296-y http://scihub22266oqcxt.onion/10.1186/s40779-020-00296-y 33402220!7785400!33402220     free     free     free       Mil+Med+Res 2021 ; 8 (1): 1 Nephropedia Template TP {{tp|p=33402220|t=2021. SARS-CoV-2: vaccines in the pandemic era |pdf=|usr=}}{{33402220}} gab.com Text SARS-CoV-2: vaccines in the pandemic era JO: Mil Med Res http://www.kidney.de/pget.php?&tw=1&pmid=33402220 #FOAvip Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019. As there is little or no natural immunity in the human population or specific anti-COVID-19 drugs, researchers from the government, academia and industry are developing vaccines at an unprecedented speed to halt the pandemic. In this review, the results of animal experiments and clinical trials on several vaccine technical platforms are summarized, and several challenges are also discussed to further promote the development, evaluation and application of vaccines during the challenging situation of the global pandemic. Twit Text FOAVip SARS-CoV-2: vaccines in the pandemic era ????Mil Med Res http://www.kidney.de/pget.php?&tw=1&pmid=33402220 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33402220 #FOAvip English Wikipedia <ref>{{Cite pmid|33402220}}</ref> SARS-CoV-2: vaccines in the pandemic era #MMPMID33402220 Li DD; Li QH Mil Med Res 2021[Jan]; 8 (1): 1 PMID33402220show ga Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019. As there is little or no natural immunity in the human population or specific anti-COVID-19 drugs, researchers from the government, academia and industry are developing vaccines at an unprecedented speed to halt the pandemic. In this review, the results of animal experiments and clinical trials on several vaccine technical platforms are summarized, and several challenges are also discussed to further promote the development, evaluation and application of vaccines during the challenging situation of the global pandemic. |*COVID-19 Vaccines[MESH] |Animals[MESH] |COVID-19/*prevention & control[MESH] |Clinical Trials as Topic[MESH] |Drug Evaluation/methods[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH]SARS-CoV-2: vaccines in the pandemic era (epmc).pdf DeepDyve Pubget Overpricing